Modalis Therapeutics Income Statement

Financials in millions JPY. Fiscal year is January - December.

Millions JPY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2019 - 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2019 - 2020
Revenue	-	-	-	40	1	342	Upgrade
Revenue Growth (YoY)	-	-	-	3900.00%	-99.71%	-46.89%	Upgrade
Gross Profit	-	-	-	40	1	342	Upgrade
Selling, General & Admin	248.67	220	248	213	196	174	Upgrade
Research & Development	2,092	1,092	2,102	1,861	1,009	531	Upgrade
Other Operating Expenses	-	25	20	29	35	35	Upgrade
Operating Expenses	2,341	1,337	2,370	2,103	1,240	740	Upgrade
Operating Income	-2,341	-1,337	-2,370	-2,063	-1,239	-398	Upgrade
Interest Expense	-3.32	-8	-15	-4	-1	-	Upgrade
Currency Exchange Gain (Loss)	-34.5	64	39	76	12	-4	Upgrade
Other Non Operating Income (Expenses)	828.01	-23	-6	-4	1	-38	Upgrade
EBT Excluding Unusual Items	-1,549	-1,304	-2,352	-1,995	-1,227	-440	Upgrade
Gain (Loss) on Sale of Assets	-	-	-	-	-2	-	Upgrade
Asset Writedown	-20.96	-	-38	-996	-	-	Upgrade
Other Unusual Items	13.64	-13	-	285	485	-	Upgrade
Pretax Income	-1,556	-1,317	-2,390	-2,706	-744	-440	Upgrade
Income Tax Expense	1.03	-	1	-4	-6	8	Upgrade
Net Income	-1,557	-1,317	-2,391	-2,702	-738	-448	Upgrade
Net Income to Common	-1,557	-1,317	-2,391	-2,702	-738	-448	Upgrade
Shares Outstanding (Basic)	65	46	31	29	29	26	Upgrade
Shares Outstanding (Diluted)	65	46	31	29	29	26	Upgrade
Shares Change (YoY)	93.23%	48.96%	6.39%	1.23%	9.12%	11.78%	Upgrade
EPS (Basic)	-23.82	-28.55	-77.21	-92.83	-25.67	-17.00	Upgrade
EPS (Diluted)	-23.82	-28.55	-77.21	-92.83	-25.67	-17.00	Upgrade
Free Cash Flow	-1,411	-1,432	-2,293	-2,092	-854	-392	Upgrade
Free Cash Flow Per Share	-21.59	-31.05	-74.05	-71.87	-29.70	-14.88	Upgrade
Gross Margin	-	-	-	100.00%	100.00%	100.00%	Upgrade
Operating Margin	-	-	-	-5157.50%	-123900.00%	-116.37%	Upgrade
Profit Margin	-	-	-	-6755.00%	-73800.00%	-130.99%	Upgrade
Free Cash Flow Margin	-	-	-	-5230.00%	-85400.00%	-114.62%	Upgrade
EBITDA	-2,340	-1,336	-2,369	-1,940	-1,162	-341	Upgrade
EBITDA Margin	-	-	-	-	-	-99.71%	Upgrade
D&A For EBITDA	1.13	0.73	0.73	123	77	57	Upgrade
EBIT	-2,341	-1,337	-2,370	-2,063	-1,239	-398	Upgrade
EBIT Margin	-	-	-	-	-	-116.37%	Upgrade

Source: S&P Global Market Intelligence. Standard template. Financial Sources.